The submitted applications for r&d grant would be evaluated by independent professionals from Israel and Singapore. Only after evaluation, the applications would be submitted to SIIRD for approval. The SIIRD Board usually convenes two times in a year. However, for the latest submission deadline for applications, the companies would refer to the SIIRD Board’s news and events.
The benefits of using SIIRD r&d grant would be inclusive of sharing risks from the r&d projects of the companies. Rest assured that SIIRD would not take equity from the companies funded by it. Moreover, the joint venture would not share Intellectual Property Rights of developed technologies and products. It does not require collateral from the funded companies.